09.20.18
Just Biotherapeutics, an integrated design company focused on technologies that will accelerate development of biotherapeutics and reduce their manufacturing cost, and Pandion Therapeutics, a biotechnology company developing novel therapeutics for the tissue-specific treatment of patients with autoimmune and inflammatory diseases and organ transplants, have entered into an agreement for the development and cGMP clinical manufacturing by Just of Pandion's lead program.
Just will provide Pandion with a suite of services leveraging its fully integrated technology platform, J.DESIGN. The services include cell line development, process development, and Phase 1 cGMP clinical manufacturing of a selected drug candidate to expedite Pandion's IND filing by the end of 2019.
"We value our partnership with Just to accelerate our product candidates through development and into the clinic," said Dr. Jo Viney, chief scientific officer, Pandion. "Just's expertise and guidance combined with their unique technology platform will play a critical role in the successful production of our molecules."
James Thomas, co-founder and chief executive officer, Just, said, "We are delighted to be working with the experienced and dynamic team at Pandion on the development and manufacturing of Pandion's lead program, PT101."
Just will provide Pandion with a suite of services leveraging its fully integrated technology platform, J.DESIGN. The services include cell line development, process development, and Phase 1 cGMP clinical manufacturing of a selected drug candidate to expedite Pandion's IND filing by the end of 2019.
"We value our partnership with Just to accelerate our product candidates through development and into the clinic," said Dr. Jo Viney, chief scientific officer, Pandion. "Just's expertise and guidance combined with their unique technology platform will play a critical role in the successful production of our molecules."
James Thomas, co-founder and chief executive officer, Just, said, "We are delighted to be working with the experienced and dynamic team at Pandion on the development and manufacturing of Pandion's lead program, PT101."